ECSP23031196A - PHARMACEUTICAL COMPOSITION SUITABLE FOR VAGINAL ADMINISTRATION IN THE FORM OF OVUMES AND USE THEREOF - Google Patents

PHARMACEUTICAL COMPOSITION SUITABLE FOR VAGINAL ADMINISTRATION IN THE FORM OF OVUMES AND USE THEREOF

Info

Publication number
ECSP23031196A
ECSP23031196A ECSENADI202331196A ECDI202331196A ECSP23031196A EC SP23031196 A ECSP23031196 A EC SP23031196A EC SENADI202331196 A ECSENADI202331196 A EC SENADI202331196A EC DI202331196 A ECDI202331196 A EC DI202331196A EC SP23031196 A ECSP23031196 A EC SP23031196A
Authority
EC
Ecuador
Prior art keywords
pharmaceutical composition
vaginal administration
composition suitable
ovumes
relates
Prior art date
Application number
ECSENADI202331196A
Other languages
Spanish (es)
Inventor
Albertos Alfonso Enrique Moguel
Ramos Marysol Mendoza
Original Assignee
Exeltis Pharma Mexico S A De C V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Exeltis Pharma Mexico S A De C V filed Critical Exeltis Pharma Mexico S A De C V
Publication of ECSP23031196A publication Critical patent/ECSP23031196A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a una composición farmacéutica adecuada para administración vaginal en forma de óvulos y a su fabricación. La presente invención también se refiere a dicha composición farmacéutica para utilizar en la prevención y/o tratamiento de enfermedades infecciosas del sistema reproductor femenino.The present invention relates to a pharmaceutical composition suitable for vaginal administration in the form of suppositories and its manufacture. The present invention also relates to said pharmaceutical composition for use in the prevention and/or treatment of infectious diseases of the female reproductive system.

ECSENADI202331196A 2020-10-29 2023-04-28 PHARMACEUTICAL COMPOSITION SUITABLE FOR VAGINAL ADMINISTRATION IN THE FORM OF OVUMES AND USE THEREOF ECSP23031196A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2020011523A MX2020011523A (en) 2020-10-29 2020-10-29 Pharmaceutical composition suitable for vaginal administration in the form of ovules and use thereof.

Publications (1)

Publication Number Publication Date
ECSP23031196A true ECSP23031196A (en) 2023-06-30

Family

ID=78695745

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSENADI202331196A ECSP23031196A (en) 2020-10-29 2023-04-28 PHARMACEUTICAL COMPOSITION SUITABLE FOR VAGINAL ADMINISTRATION IN THE FORM OF OVUMES AND USE THEREOF

Country Status (4)

Country Link
CL (1) CL2023001196A1 (en)
EC (1) ECSP23031196A (en)
MX (1) MX2020011523A (en)
WO (1) WO2022091016A1 (en)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ222698A (en) * 1987-01-08 1990-02-26 Squibb & Sons Inc Bioadhesive suppository formulations comprising a medicament, water, a hydrocolloid and low melting point base
IT1275816B1 (en) * 1995-10-27 1997-10-17 Montefarmaco Spa SOLID PHARMACEUTICAL COMPOSITIONS FOR VAGINAL USE
TWI232111B (en) * 1999-08-06 2005-05-11 Upjohn Co Intravaginal clindamycin ovule composition
GB0015617D0 (en) * 2000-06-26 2000-08-16 Vectura Ltd Improved preparations for dermal delivery of active substances
CN101584703B (en) * 2008-05-21 2011-11-09 杨立新 Pharmaceutical composition for treating colpitis and preparation method thereof
KR20130130403A (en) * 2012-05-22 2013-12-02 울산대학교 산학협력단 Composition for treating or reducing poastoperative wound pain in laparoscopic assisted vaginal hysterectomy
CN103520090B (en) * 2013-10-11 2015-12-09 哈尔滨欧替药业有限公司 Tinidazole vaginal expansible plug and preparation method thereof and detection method

Also Published As

Publication number Publication date
WO2022091016A1 (en) 2022-05-05
CL2023001196A1 (en) 2023-10-20
MX2020011523A (en) 2022-05-02

Similar Documents

Publication Publication Date Title
AR115939A2 (en) COMPOSITION CONTAINING ULTRA-MICRONIZED PALMITOYL-ETHANOLAMIDE
DOP2023000187A (en) ANTIBODIES TARGETTING HIV GP120 AND METHODS OF USE
MX2020009758A (en) Combination product of bcl-2 inhibitor or bcl-2/bcl-xl dual inhibitor and btk inhibitor and use thereof in the prevention and/or treatment of diseases.
BR112015024411A2 (en) macrocyclic desaza purinones for the treatment of viral infections
CU24065B1 (en) PHARMACEUTICAL DOSAGE FORM INCLUDING NIFEDIPINO AND AN ANTAGONIST OF ANGIOTENSIN II
GT200600445A (en) SOLID PHARMACEUTICAL PRESENTATION FORMS OF ORAL ADMINISTRATION WITH QUICK RELEASE OF THE ACTIVE PRINCIPLE.
BR112015032546A2 (en) pyrrolo [3,2-d] pyrimidine derivatives for the treatment of viral infections and other diseases
CL2016002276A1 (en) Topical compositions comprising an extract of coriolus versicolor to increase autoimmunity
BR112017000285A2 (en) viral prophylaxis treatment methods and pre-exposure prophylaxis kits
ES2429422R1 (en) Pharmaceutical composition and its use to prepare a medicine for the treatment and prevention of HIV diseases
CR20210507A (en) Aqueous pharmaceutical composition of an anti-il17a antibody and use thereof
CO7111317A2 (en) Method for the treatment of gynecological diseases
ECSP23031196A (en) PHARMACEUTICAL COMPOSITION SUITABLE FOR VAGINAL ADMINISTRATION IN THE FORM OF OVUMES AND USE THEREOF
CL2022003743A1 (en) Dispersible tablet formulations comprising dolutegravir
BR112022014772A2 (en) Amorphous SOLID DISPERSION, PHARMACEUTICAL COMPOSITION AND PROCESSES FOR THE PREPARATION OF THESE
CL2022003426A1 (en) Levilimab Aqueous Pharmaceutical Composition and Its Use
BR112015028890A2 (en) Pyridone derivatives for the treatment of viral infections and other diseases
CL2019002020A1 (en) A pharmaceutical composition comprising an oxazine derivative and its use in the treatment or prevention of Alzheimer's disease.
CL2018002705A1 (en) Glucono delta-lactone for the treatment of vaginal fungal infections
CO2022002493A2 (en) 18p-glycyrrhetinic acid nanoemulsion
CL2017001679A1 (en) Use of saponaria keel extracts for the prevention and control of bacterial infections in fish
CO2018010142A2 (en) Mesalazine solid formula preparation process
BR112022010340A2 (en) PHARMACEUTICAL COMPOSITIONS
CL2019003288A1 (en) A pharmaceutical combination for the treatment of cancer.
MX2020004105A (en) Pharmaceutical formulation.